Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiying Qiu

Showing results (51-60 of 194) with videos related to

Pageof 20
Sort By:
Diabetes Research and Clinical Practice|February 15, 2018
Pathophysiological changes after lipopolysaccharide-induced acute inflammation in a type 2 diabetic rat model versus normal controlsTingting Han, Xingxing Ren, Dongdong Jiang, et al.
Clinical and Experimental Medicine|July 17, 2025
DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosisHuiquan Wang, Jiafeng Zhang, Lei Chen, et al.
Leukemia & Lymphoma|November 16, 2020
Allogeneic hematopoietic stem cell transplantation could improve survival for pure CBF-AML patients with minimal residual disease positive after the second consolidationTanzhen Wang, Biqi Zhou, Jubin Zhang, et al.
Bone Marrow Transplantation|September 6, 2020
The role of EVI1 gene quantification in AML patients with 11q23/MLL rearrangement after allogeneic hematopoietic stem cell transplantationShuhui Jiang, Yi Fan, Yanglan Fang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[The clinical efficacy of the patients of acute myeloid leukemia and myelodysplastic syndromes treated with decitabine alone, combined with half or one couse of CAG regimen]Su Gao, Huiying Qiu, Zhengming Jin, et al.
Hematology (Amsterdam, Netherlands)|July 18, 2015
Deep molecular responses achieved in chronic myeloid leukemia in chronic phase patients with BCR-ABL1 >10% at 3 months who are early switched to nilotinibYanhua Yue, Xiaomin Gui, Xuefeng He, et al.
Transplantation and Cellular Therapy|April 8, 2021
Allogeneic Hematopoietic Stem Cell Transplantation Improved Survival for Adult Core Binding Factor Acute Myelogenous Leukemia Patients with Intermediate- and Adverse-Risk Genetics in the 2017 European LeukemiaNetTanzhen Wang, Sifan Chen, Jia Chen, et al.
Clinical and Experimental Pharmacology & Physiology|June 2, 2016
CD19(+) CD20(-) CD27(hi) IL-s10-producing B cells are overrepresented in R-CHOP-treated DLBCL patients in complete remissionHuiying Qiu, Junguo Li, Zhenjun Feng, et al.
Cancer Genetics|November 5, 2016
Clinical and molecular cytogenetic studies in ten patients with hematological malignancies characterized by t(20;21)(q11;q11) resulted from del(20q)Chunxiao Wu, Jun Zhang, Shuxiao Bai, et al.
Frontiers in Oncology|July 28, 2022
Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell TransplantationHong Wang, Jiaqian Qi, Xueqian Li, et al.
Pageof 20

Showing results (51-60 of 194) with videos related to

Sort By:
Pageof 20
Diabetes Research and Clinical Practice|February 15, 2018
Pathophysiological changes after lipopolysaccharide-induced acute inflammation in a type 2 diabetic rat model versus normal controlsTingting Han, Xingxing Ren, Dongdong Jiang, et al.
Clinical and Experimental Medicine|July 17, 2025
DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosisHuiquan Wang, Jiafeng Zhang, Lei Chen, et al.
Leukemia & Lymphoma|November 16, 2020
Allogeneic hematopoietic stem cell transplantation could improve survival for pure CBF-AML patients with minimal residual disease positive after the second consolidationTanzhen Wang, Biqi Zhou, Jubin Zhang, et al.
Bone Marrow Transplantation|September 6, 2020
The role of EVI1 gene quantification in AML patients with 11q23/MLL rearrangement after allogeneic hematopoietic stem cell transplantationShuhui Jiang, Yi Fan, Yanglan Fang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[The clinical efficacy of the patients of acute myeloid leukemia and myelodysplastic syndromes treated with decitabine alone, combined with half or one couse of CAG regimen]Su Gao, Huiying Qiu, Zhengming Jin, et al.
Hematology (Amsterdam, Netherlands)|July 18, 2015
Deep molecular responses achieved in chronic myeloid leukemia in chronic phase patients with BCR-ABL1 >10% at 3 months who are early switched to nilotinibYanhua Yue, Xiaomin Gui, Xuefeng He, et al.
Transplantation and Cellular Therapy|April 8, 2021
Allogeneic Hematopoietic Stem Cell Transplantation Improved Survival for Adult Core Binding Factor Acute Myelogenous Leukemia Patients with Intermediate- and Adverse-Risk Genetics in the 2017 European LeukemiaNetTanzhen Wang, Sifan Chen, Jia Chen, et al.
Clinical and Experimental Pharmacology & Physiology|June 2, 2016
CD19(+) CD20(-) CD27(hi) IL-s10-producing B cells are overrepresented in R-CHOP-treated DLBCL patients in complete remissionHuiying Qiu, Junguo Li, Zhenjun Feng, et al.
Cancer Genetics|November 5, 2016
Clinical and molecular cytogenetic studies in ten patients with hematological malignancies characterized by t(20;21)(q11;q11) resulted from del(20q)Chunxiao Wu, Jun Zhang, Shuxiao Bai, et al.
Frontiers in Oncology|July 28, 2022
Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell TransplantationHong Wang, Jiaqian Qi, Xueqian Li, et al.
Pageof 20